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Spot urine samples have been used to assess 
organophosphorous (OP) pesticide exposures 
in epidemiological and biomonitoring studies, 
with samples analyzed for either nonspecific 
dialkyl phosphate (DAP) metabolites [Centers 
for Disease Control and Prevention (CDC) 
2003] or pesticide-specific metabolites (Fenske 
et al. 2002). Because collection of spot urine 
samples is relatively simple and noninvasive, 
this sample type is commonly used in stud-
ies involving children (Fenske et al. 2005). 
Several studies suggest that spot samples 
provide meaningful measures of exposure, 
reporting associations, for example, between 
residence near farmlands and OP metabolite 
levels in children’s urine (Fenske et al. 2000). 
However, concerns have been raised as to 
whether metabolites measured in a single spot 
sample accurately reflect exposure for the full 
day or beyond.
Several factors may result in exposure 
misclassification when using spot samples: 
a) Because the concentration of a chemical, 
urine volume, and rate of urinary excretion 
vary with fluid and salt intake, time of day, 
and other factors (Barr et al. 2005; Boeniger 
et al. 1993; Cornelis et al. 1996), exposure 
measurements may be more variable than 
other sample types, such as first morning voids 
(FMVs) (Kissel et al. 2005), which are more 
concentrated and reflect a longer period of 
accumulation, or 24-hr urine collections, con-
sidered by some as the “gold standard” (Aprea 
et al. 2002; Boeniger et al. 1993; Fenske and 
Elkner 1990; Martin et al. 1996); b) because 
of within-child variability in creatinine excre-
tion (Barr et al. 2005; Boeniger et al. 1993), 
creatinine adjustment may introduce new vari-
ability that does not reflect urine dilution; and 
c) most OP pesticides have biological half-lives 
of only 12–36 hr (Needham 2005) and are 
metabolized and excreted from the body in 
hours to days (Barr 2008). Thus, OP pesti-
cide metabolite excretion in a brief sampling 
period, whether measured in a spot, FMV, 
or 24-hr urine sample, may not accurately 
represent a child’s cumulative OP pesticide 
exposure over longer periods.
One recent study of 44 preschool-age 
children who provided between 10 and 26 
biweekly spot urine samples over 21 months 
reported that within-child variability for the five 
DAP metabolites measured exceeded between-
child variability by several factors (Griffith et al. 
2011)—a finding that underscores concern 
about the reliability of this measure and raises 
questions about the source of within-child vari-
ability. To date, no studies have evaluated vari-
ability of OP metabolites in within-day samples 
or in 24-hr urine samples collected several days 
apart. Nor have studies compared variability in 
DAP measurements when expressed in terms of 
unadjusted concentrations, creatinine-adjusted 
concentrations, or urinary excretion rates.
To address these questions, in this study 
with preschool-aged children in California we 
aimed to a) evaluate the reproducibility of chil-
dren’s nonspecific OP pesticide measurements 
within a 1-week period; b) evaluate the influ-
ence of concentration corrections (i.e., creati-
nine adjustment and use of urinary excretion 
rate) on reproducibility of DAP measurements; 
c) determine the degree of correspondence 
between pesticide metabolite concentration 
in spot urine samples (including FMVs) and 
same-day 24-hr samples; and d) evaluate the 
sensitivity and specificity of spot urine samples 
to classify full-week average measurements.
Methods
Study population. We recruited a convenience 
sample of 25 children (10 boys, 15 girls) from 
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Background: Dialkyl phosphate (DAP) metabolites in spot urine samples are frequently used to 
characterize children’s exposures to organophosphorous (OP) pesticides. However, variable expo-
sure and short biological half-lives of OP pesticides could result in highly variable measurements, 
leading to exposure misclassification.
oBjective: We examined within- and between-child variability in DAP metabolites in urine sam-
ples collected during 1 week.
Methods: We collected spot urine samples over 7 consecutive days from 25 children (3–6 years of 
age). On two of the days, we collected 24-hr voids. We assessed the reproducibility of urinary DAP 
metabolite concentrations and evaluated the sensitivity and specificity of spot urine samples as pre-
dictors of high (top 20%) or elevated (top 40%) weekly average DAP metabolite concentrations.
results: Within-child variance exceeded between-child variance by a factor of two to eight, 
depending on metabolite grouping. Although total DAP concentrations in single spot urine samples 
were moderately to strongly associated with concentrations in same-day 24-hr samples (r ≈ 0.6–0.8, 
p < 0.01), concentrations in spot samples collected > 1 day apart and in 24-hr samples collected 
3 days apart were weakly correlated (r ≈ –0.21 to 0.38). Single spot samples predicted high (top 
20%) and elevated (top 40%) full-week average total DAP excretion with only moderate sensitivity 
(≈ 0.52 and ≈ 0.67, respectively) but relatively high specificity (≈ 0.88 and ≈ 0.78, respectively).
conclusions: The high variability we observed in children’s DAP metabolite concentrations sug-
gests that single-day urine samples provide only a brief snapshot of exposure. Sensitivity analyses 
suggest that classification of cumulative OP exposure based on spot samples is prone to type 2 
 classification errors.
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clinics serving low-income families in the 
Salinas Valley, an agricultural region. Eligible 
children were between 3 and 6 years old, in 
good health with no history of diabetes or 
renal disease, toilet-trained, free of enuresis, 
and had English- or Spanish-speaking moth-
ers who were at least 18 years old. Sampling 
occurred in March and April 2004. The study 
was approved by the University of California 
at Berkeley Committee for the Protection of 
Human Subjects, and parents provided written 
informed consent.
Urine sample collection. Each family par-
ticipated for 7 consecutive days (study days 
1–7). On day 1, study staff provided families 
with sampling supplies and instructions on 
sample collection. Supplies included speci-
men trays (cleaned, sterile Specipan™; Baxter 
Scientific, McGaw Park, IL), gloves, collec-
tion jars with blank labels, a small refrigera-
tor, and two 24-hr sampling record forms. 
On spot-sampling days (1, 3, 4, 6, and 7), 
families collected a single void at their conve-
nience; families sometimes collected an FMV 
as the spot sample. On 24-hr sampling days 
(2 and 5), families were instructed to collect 
the child’s FMV, all daytime and evening spot 
voids, and the FMV of the following day as 
separate specimens, and to note the timing of 
all voids (including missed voids) during this 
period on the 24-hr sampling record form.
Sample collection methods have been pre-
viously validated in this age range (Lu et al. 
2001). Children voided directly into a col-
lection jar or into a clean, sterile specimen 
tray placed on a training potty or toilet. If 
samples were collected in specimen trays, par-
ents transferred specimens into collection jars. 
Parents identified each sample as an FMV or 
a non-FMV spot sample, recorded the time 
of collection on jar labels, and stored speci-
mens in the refrigerator until daily collection 
by research staff. On 24-hr sampling days, 
research staff reviewed the sampling record 
form with the families to assure its accuracy 
and completeness.
Twenty-four-hour samples included 3–11 
collected voids (mean, 6.5). Overall, 86% 
(range, 50–100%) of the reported voids dur-
ing the 24-hr sampling periods were collected. 
Twenty-two (44%) of the 24-hr samples 
were based on 100% collection of all voids. 
Reasons for missed voids included out-of-
home bathroom use, toileting accidents, and 
participant error, such as missing an evening 
void. In sensitivity analyses, we excluded seven 
24-hr samples with fewer than five total voids 
to confirm that collection errors did not sub-
stantially change study results (not shown).
Sample processing and analysis. Samples 
were processed at the Salinas Valley study 
office. The weight of each void was measured 
(grams), and the volume (milliliters) was esti-
mated assuming a urine specific gravity of 
1.022 (Salita et al. 1998). Individual voids 
from 24-hr sampling sessions that were not 
selected for individual analysis were pooled. 
After aliquotting, samples were stored at 
–80°C until being shipped on dry ice to the 
CDC for analysis.
We measured six DAP metabolites in 
all samples: three dimethyl (DM) phosphate 
metabolites—dimethylphosphate (DMP), 
dimethyl thio phosphate (DMTP), and 
dimethyl dithio phosphate (DMDTP); and three 
diethyl (DE) phosphates—diethyl phosphate 
(DEP), diethylthiophosphate (DETP), and 
diethyldithiophosphate (DEDTP). These 
metabolites represent approximately 81% of the 
agricultural OP pesticides used in the Salinas 
Valley (Bradman et al. 2007). Laboratory meth-
ods and quality control procedures are described 
in detail elsewhere (Bravo et al. 2004). Briefly, 
samples were lyophilized to remove water, 
redissolved in a 1:1 solution of acetonitrile and 
diethyl ether, and analyzed using gas chroma-
tography–tandem mass spectrometry using iso-
tope dilution. Creatinine concentrations were 
determined using a commercially available 
method (Vitros CREA slides; Ortho Clinical 
Diagnostics, Raritan, NJ). Westgard rules for 
quality control were used to establish the valid-
ity of each analytical run (Westgard 2003). 
Limits of detection (LODs) were 0.2 μg/L 
for all DEs, 0.5 μg/L for DMP, 0.4 μg/L for 
DMTP, and 0.1 μg/L for DMDTP.
Levels below the LOD were imputed as 
LOD/√
–2 (Hornung and Reed 1990), and molar 
concentrations were summed within each sam-
ple to yield total DM, total DE, and total DAP 
concentrations. Metabolite levels in 24-hr voids 
were computed as the volume-weighted aver-
age of concentrations in all samples collected 
on sampling days 2 and 5, which included the 
FMV samples from the following day. We 
expressed metabolite concentration and/or 
excretion in three ways: a) unadjusted metabo-
lite concentration (nanomoles metabolite per 
liter of urine); b) creatinine-adjusted metabolite 
concentration (nanomoles metabo lite per gram 
of creatinine); and c) urinary excretion rate 
(UER) of each metabolite (nanomoles metabo-
lite per minute) computed as the total moles 
of excreted metabolite divided by the duration 
of time in minutes since the previous void. For 
24-hr collections, time since the previous void 
was calculated as the time elapsed between the 
last void preceding the 24-hr sample collection 
(typically the last void on day 1 or 4) and the 
last void included in the 24-hr sample (typically 
the FMV on day 3 or 6).
Data Analysis
Statistical analyses were performed using Stata 
10 for Windows (StataCorp LP, College Station, 
TX). We first computed descriptive statistics 
and assessed normality. Log10-transformed 
 values were used for subsequent analyses.
Correspondence between spot samples 
and 24-hr samples. We constructed gener-
alized estimating equation (GEE) models 
using DAP concentration in a 24-hr sample 
as the outcome variable and concentration in 
a same-day spot sample (FMV or non-FMV) 
or a combination of these two spot samples as 
the predictor variable. Combinations of two 
spot samples were modeled as separate predic-
tor variables and as a single variable computed 
as either the arithmetic or volume-weighted 
average of the individual samples. Analyses 
using each DAP variable type (i.e., unadjusted 
concentrations, creatinine-adjusted concen-
trations, and UER) were compared. Robust 
standard errors were calculated.
Reproducibility of spot and 24-hr urine 
samples. We used mixed random-effects 
 models to compute the between-child and 
within-child variance for 24-hr samples from 
days 2 and 5, and for all FMV spot samples. 
For all non-FMV spot samples and for all 
spot samples (FMV and non-FMV), we esti-
mated the variance attributable to each of three 
nested components—between-child, within-
child, and within-child within-day variability 
(because multiple samples were available from 
the same day)—using two-level random-inter-
cept  models (Marchenko 2006). This method 
parses the total within-child variance into two 
parts: the component attributable to same-
day within-child variability, and the compo-
nent attributable to between-day within-child 
variability (Hauser et al. 2004; Preau et al. 
2010; Ye et al. 2011). We calculated Akaike 
Information Criterion (AIC) values for the 
nested  models with the largest number of 
observations (the all spot samples model) to 
compare the fit of models using unadjusted 
DAP concentrations, creatinine-adjusted con-
centrations, and UER. We also calculated the 
intraclass correlation coefficient (ICC) for 
each group of samples. The ICC is the ratio of 
between-subject  variance to total variance.
Correlation of spot samples collected 
0–6 days apart. We computed Pearson’s cor-
relations between pairs of samples collected on 
the same day (0 days apart) as well as on pairs 
of samples collected between 1 and 6 days 
apart. This analysis included all possible unique 
pairings of each child’s spot samples, and was 
conducted separately for pairs of FMV spots 
only, pairs of non-FMV spots only, and for all 
pairs of spots regardless of FMV status. Tests 
of significance were computed using a robust 
estimate of the variance.
Sensitivity and specificity. We evaluated the 
sensitivity and specificity of one, two, or three 
randomly-selected spot urine samples from each 
child as predictors of high (top 20%) or elevated 
(top 40%) weekly average DAP metabolite con-
centrations. For “true” exposure, we calculated 
the arithmetic mean metabolite concentration 
of all spot urine samples collected from each 
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child during the week, categorized these in 
quintiles, and assigned “true” high (top 20%) or 
elevated (top 40%) exposure level. For predic-
tor sets, we created 10 data sets each containing 
one randomly selected spot sample per child 
(i.e., 25 observations total per data set). Within 
each randomly-selected data set, we again cat-
egorized the 25 metabolite concentration in 
quintiles, and assigned “predicted” high (top 
20%) or elevated (top 40%) exposure levels. 
This process mimicked the exposure classifi-
cation process in epidemiological studies, in 
which knowledge of the range and rankings 
of exposure in a population is often limited to 
what can be observed in the single sample or 
small number of samples collected per subject. 
The sensitivity and specificity figures we report 
represent the average sensitivity and specificity 
observed across the 10 separate random sam-
ples. We report findings separately for FMV 
samples only, for non-FMV samples only, and 
for all spot samples. To determine whether 
collection of more than one spot sample could 
improve sensitivity, we repeated this analysis 
using the arithmetic mean of two or three spot 
samples from each child collected on differ-
ent days. Because some children lacked three 
FMV or non-FMV samples from different 
days, we only assessed the sensitivity and speci-
ficity of three spot samples in the “any spot 
sample” group.
Results
All children were Mexican American, and their 
ages ranged from 3 to 6.5 years (mean ± SD 
age, 4.5 ± 0.93 years). Children urinated 
between 3 and 12 times (mean, 5.7 voids) per 
24-hr period, and the volume of their individ-
ual spot samples ranged from 4.8 to 642.2 mL 
(mean, 146.6 mL) for FMV samples and 
Table 1. Unadjusted and creatinine-adjusted DAP concentrations in urine samples.
Type of sample DF (%)
Unadjusted Creatinine adjusted
GM Mean Median Max GM Mean Median Max
Non-FMV spot samples (n = 137)
Total DAPs 99.3 110 239 122 4,820 196 529 218 20,600
Total DMs 94.2 63.0 179 60.3 4,790 112 436 96.2 20,500
Total DEs 95.6 26.8 59.8 31.1 500 47.7 98.8 68.0 529
FMV samples (n = 110)
Total DAPs 98.2 162 307 157 2,530 205 483 200 11,800
Total DMs 95.5 92.3 234 94.4 2,380 117 392 124 11,600
Total DEs 97.3 43.4 72.5 57.1 391 55.1 91.1 77.6 376
24-hr samples (n = 50)
Total DAPs — 158.0 296 144 3,700 275 621 245 10,100
Total DMs — 94.6 230 89.9 3,590 166 508 139 9,920
Total DEs — 45.9 65.0 53.3 248 78.9 113 93.6 610
Abbreviations: DF, detection frequency; GM, geometric mean; Max, maximum.
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Figure 1. Concentration of total DAP metabolites (nmol/ gram creatinine) in log10 scale for all spot samples and 24-hr samples collected over 1 week. Each panel 
represents an individual participant (n = 25; P1–P25.) The dots in each panel represent the total DAP metabolite concentration in the 24-hr samples from sampling 
days 2 and 5, respectively. The panels are ranked in order of ascending arithmetic mean of all spot samples collected for each child. Thus, the bottom row (P21–
P25) contains the children rated as having “true” high (top 20%) weekly exposure in the sensitivity and specificity analysis, and the bottom two rows (P16–P25) 
contain the children with “true” elevated (top 40%) weekly exposure.
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from 8.4 to 238.3 mL (mean, 68.1 mL) for 
non-FMV spot samples. The creatinine con-
centration of spot samples ranged from 9.4 
to 213.2 mg/dL (mean, 86.6 mg/dL) for 
FMV samples and from 4.5 to 158.7 mg/dL 
(mean, 68.6 mg/dL) for non-FMV samples. 
Creatinine concentration varied more within 
children than between children for both FMV 
(ICC = 0.37) and non-FMV (ICC = 0.22) 
spot samples. Individual DE and DM metab-
olites were detected in > 70% of samples, 
except for DEDTP (17%) (data not shown). 
Total DM concentrations exceeded total DE 
concentrations, and total DAP levels reflected 
predominantly DM metabolites (Table 1). 
Central tendency measures (e.g., means, medi-
ans) for unadjusted concentration values were 
similar for FMV spot samples and 24-hr sam-
ples, which were generally higher than levels 
in non-FMV spot samples. In contrast, cen-
tral tendency measures for creatinine- adjusted 
concentration values were more similar for 
FMVs and non-FMV spot samples, with 
both generally lower than creatinine- adjusted 
24-hr samples.
Figure 1 presents the total DAP metabo-
lite concentrations [in log10 scale (nanamoles 
per gram creatinine)] for each participant for 
all spot samples collected over the 7 consecu-
tive sampling days. There are no clear expo-
sure trends over time among the children, 
though our data indicate that shifts of up to 
two orders of magnitude can occur over the 
week (Figure 1, P7) or within a single day 
(Figure 1, P19, day 5). Twenty-four-hour 
samples collected only 3 days apart can like-
wise differ by an order of magnitude (e.g., 
Figure 1, P2, P7, P25).
Table 2 presents results of GEE models 
examining how well same-day spot samples 
predict 24-hr metabolite levels. For models 
examining a single unadjusted spot sample 
(FMV or non-FMV) and its respective 24-hr 
sample, the predictive power of the model, 
defined by the coefficient of determination 
(R2), was highest for FMVs [R2 for total DAP 
metabolites (nmol/L) = 0.54 for FMVs vs. 
0.39 for non-FMV spots]. The predictive 
power of the model was higher for creatinine-
adjusted metabolites compared with unad-
justed metabolites, especially for non-FMVs, 
with little difference between the sample types 
(total DAP R2 = 0.57 for FMV and 0.63 for 
non-FMVs). The predictive power was lowest 
for UER models.
The best-fitting models were obtained 
when the arithmetic mean of an FMV and 
a non-FMV sample was used to predict the 
24-hr values (Table 2). The best model fit was 
observed for creatinine-adjusted values (total 
DAP R2 = 0.84), but the variability in 24-hr 
metabolite levels explained by unadjusted 
values and UER estimates were comparable 
(R2 = 0.79 and 0.77, respectively). Model fit 
was strongest for analyses of total DM metabo-
lites, and weakest for total DE metabolites. 
Volume-weighted averages of FMV and non-
FMV spots produced model fits that were sim-
ilar to that obtained with the arithmetic mean 
(data not shown). Results of sensitivity analyses 
that excluded seven 24-hr samples with fewer 
than five spot samples were consistent with 
those described above (data not shown).
AIC values for mixed random-effects 
models used to estimate the variance in total 
DAPs attributable to between-child versus 
within-child sources based on all spot urine 
samples (n = 247) indicated that best model fit 
was achieved with creatinine-adjusted values 
(AIC = 364; Table 3) versus AIC = 372 and 
451, respectively, for unadjusted concentration 
and UER models [see Supplemental Material, 
Table S1 (http://dx.doi.org/10.1289/
ehp.1104808)]. Relative to unadjusted con-
centration and UER models, use of creatinine-
 adjusted values also provided the greatest 
degree of distinction between individual chil-
dren [e.g., ICC = 0.32 for creatinine-adjusted 
total DAP metabolites in the “any spot sam-
ple” model (Table 3) vs. ICC = 0.21 and 0.15, 
respectively, for the analogous unadjusted con-
centration and UER models (see Supplemental 
Material, Table S1)].
Among creatinine-adjusted total DAP 
concentration models (Table 3), non-FMV 
spot samples displayed the poorest reproduc-
ibility (ICC = 0.27 for creatinine-adjusted 
total DAP metabolites). Inclusion of FMV 
samples in this analysis (the “any spot sample” 
set) modestly increased the between-child rela-
tive to within-child variance (ICC = 0.32) and 
suggested somewhat more between-day sta-
bility in measures (i.e., smaller within-child 
between-day variance). However, examina-
tion of 24-hr voids collected 3 days apart 
indicates that this between-day stability was 
limited, with 65% of total variance attrib-
uted to within-child variability (Table 3). A 
sensitivity analysis limited to the most com-
plete 24-hr samples (based on five or more 
spot samples) indicated even greater within-
child variance (for total DAPs, 77% of total, 
ICC = 0.23; data not shown). The variance 
components of creatinine- adjusted total DM 
metabolites (Table 3) were similar to those 
for total DAP metabolites, though the repro-
ducibility of DM samples was slightly higher 
(ICCs = 0.30–0.39, compared with 0.27–0.35 
for total DAPs). Reproducibility of creatinine-
adjusted DE metabolites was much lower 
(ICCs = 0.11–0.16) (Table 3), and within-
child variance exceeded between-child variance 
Table 2. Modeling of 24-hr metabolite excretiona using same-day spot urine samples as predictors (n = 41b).
Type of spot sample/
metabolite excretion unitsc
Metabolite 
type
Regression model
Pearson 
correlation
β (95% CI) Intercept Model R 2 r p-Value
Non-FMV spot
Unadjusted (nmol/L) Total DAPs 0.52 (0.28, 0.76) 1.11 0.39 0.63 < 0.001
Total DMs 0.60 (0.41, 0.78) 0.86 0.49 0.70 < 0.001
Total DEs 0.25 (0.06, 0.43) 1.30 0.14 0.37 0.011
Creatinine adjusted 
(nmol/g creatinine)
Total DAPs 0.66 (0.48, 0.84) 0.87 0.63 0.80 < 0.001
Total DMs 0.69 (0.53, 0.84) 0.74 0.68 0.82 < 0.001
Total DEs 0.33 (0.16, 0.50) 1.31 0.25 0.50 < 0.001
Urinary excretion rate 
(nmol/min)
Total DAPs 0.51 (0.23, 0.79) –0.69 0.42 0.65 0.001
Total DMs 0.57 (0.37, 0.77) –0.72 0.52 0.72 < 0.001
Total DEs 0.21 (0.01, 0.40) –1.49 0.09 0.30 0.036
FMV spot
Unadjusted (nmol/L) Total DAPs 0.66 (0.42, 0.90) 0.70 0.54 0.74 < 0.001
Total DMs 0.66 (0.42, 0.89) 0.66 0.57 0.75 < 0.001
Total DEs 0.39 (0.18, 0.60) 0.99 0.26 0.51 0.001
Creatinine-adjusted 
(nmol/g creatinine)
Total DAPs 0.75 (0.50, 1.01) 0.68 0.57 0.76 < 0.001
Total DMs 0.72 (0.47, 0.97) 0.71 0.59 0.77 < 0.001
Total DEs 0.41 (0.19, 0.63) 1.15 0.27 0.52 0.001
Urinary excretion rate 
(nmol/min)
Total DAPs 0.43 (0.13, 0.74) –0.72 0.37 0.60 0.008
Total DMs 0.51 (0.22, 0.79) –0.71 0.45 0.67 0.001
Total DEs 0.26 (0.04, 0.49) –1.36 0.19 0.43 0.025
Average of non-FMV and FMV spotsd
Unadjusted (nmol/L) Total DAPs 0.90 (0.76, 1.05) 0.17 0.79 0.89 < 0.001
Total DMs 0.92 (0.78, 1.07) 0.09 0.84 0.92 < 0.001
Total DEs 0.66 (0.78, 1.07) 0.57 0.44 0.66 < 0.001
Creatinine-adjusted 
(nmol/g creatinine)
Total DAPs 0.92 (0.81, 1.03) 0.20 0.84 0.92 < 0.001
Total DMs 0.93 (0.81, 1.04) 0.14 0.89 0.94 < 0.001
Total DEs 0.70 (0.44, 0.96) 0.60 0.48 0.69 < 0.001
Urinary excretion rate 
(nmol/min)
Total DAPs 0.83 (0.64, 1.03) –0.30 0.77 0.88 < 0.001
Total DMs 0.85 (0.69, 1.01) –0.32 0.82 0.91 < 0.001
Total DEs 0.66 (0.34, 0.99) –0.67 0.39 0.62 < 0.001
aSpot and 24-hr samples analyzed on log10 scale. bn = 41 child-days; 9 samples lacked an FMV sample and were excluded. 
Regression models are clustered by child. cUnits of both the spot sample(s) and the 24-hr sample. dValues converted to 
log10 scale after arithmetic average of concentrations on normal scale was computed; not volume-weighted.
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between a factor between five (e.g., 57% vs. 
12% of the total variance for non-FMV spot 
samples) and eight (e.g., 88% vs. 12% of 
the total variance for FMV spot samples) for 
these metabolites.
On the basis of their superior model 
 performance in the preceding analyses, we 
used  creatinine- adjusted values in subsequent 
analyses.
Table 4 presents Pearson correlations of 
creatinine-adjusted metabolite levels in spot 
samples collected 0–6 days apart. Correlations 
for total DAPs and total DMs were moderate 
(≈ 0.5) and statistically significant for samples 
collected on the same day (i.e., 0 days apart) 
or 1 day apart, and became weaker as the 
number of days between samples increased. 
All correlations were weak and not signifi-
cant for samples collected 5–6 days apart. DE 
metabolites had weaker correlations compared 
with DMs, and the decay in correlations across 
days was more rapid for DEs than for DM or 
total DAP metabolites. FMV samples tended 
to have higher correlations than non-FMV 
samples or any spot samples. The correlations 
between samples collected 2–3 days apart are 
comparable with Pearson correlations between 
levels in 24-hr samples collected 3 days apart, 
which were 0.35. 0.36, and 0.15, respectively, 
for total DAP, DM, and DE metabolites.
Table 5 presents results of sensitivity and 
specificity analyses. In this sample of partici-
pants, children with high (top 20%) weekly 
average total DAP metabolite concentrations 
would be correctly classified by a single non-
FMV spot sample 52% of the time. Using 
two samples increased the sensitivity margin-
ally to 56%. FMVs also showed marginally 
higher sensitivity than non-FMV samples. 
Within the “any spot sample group,” three-
spot predictors offered little apparent advan-
tage over two-spot predictors. Overall, the 
sensitivity was higher to classify children in 
the top 40th percentile (elevated) than in the 
top 20th percentile, with a slight improve-
ment with two versus one sample. Specificity 
was uniformly higher than sensitivity. Use of a 
single non-FMV spot sample would correctly 
identify a child in the lower 80th percentile 
(i.e., not “high”) 88% of the time, and would 
identify a child in the lower 60th percentile 
(i.e. not “elevated”) 78% of the time.
Discussion
This study of variability in DAP metabolites 
of OP pesticides in urine samples from chil-
dren 3–6 years old indicates high variabil-
ity over a 1-week time frame. Although we 
observed strong correlations between full-day 
24-hr samples and same-day spot samples (see 
Pearson correlations, Table 2), there was weak 
correlation between DAP metabolite levels in 
24-hr samples collected 3 days apart or in spot 
samples collected > 1 day apart, with correla-
tions weaker for DE compared with DM DAP 
metabolites. Further, within-child variance was 
approximately two to three times the between-
child variance for total DAP metabolites (e.g., 
66% vs. 34% for FMV samples for creatinine-
adjusted total DAPs, ICC = 0.27–0.35). This 
ratio was lower (and thus, the ICC higher) in 
DM metabolites compared with DE metabo-
lites (ICC = 0.30–0.39 vs. ICC = 0.11–0.16, 
respectively). Finally, we found that DAPs 
measured in one, two, or even three spot 
urine samples have relatively low sensitivity 
to identify children who would be considered 
the most highly exposed on the basis of their 
average full-week DAP concentrations. For 
example, a single non-FMV spot sample would 
correctly identify only 52% of the children 
whose true weekly exposure was in the top 
quintile, suggesting high type 2 classification 
errors; by contrast, spot samples appear to offer 
good specificity, with a single non-FMV spot 
sample correctly identifying about 88% of chil-
dren with true total DAP exposure below the 
top quintile. Overall, the high within-child 
variance, the weak correlation across days, and 
low specificity suggests that single-day measure-
ments may not adequately characterize exposure 
for longer time frames necessary for chronic risk 
assessments or epidemiologic studies.
Our analysis replicated methods applied 
by Ye et al. (2011) and Preau et al. (2010) 
to partition the variance components among 
between-child, within-child between-day, and 
within-child within-day components for sam-
ple types with more than one sample per day 
(Table 3). Similar to their findings for bisphe-
nol A and monoethyl phthalate, we found that 
overall within-person variance was higher than 
between-person variance, and that within-day 
variance was the largest component of total 
variance, suggesting that differences in expo-
sure between days were lower compared with 
fluctuations that occurred during the course of 
each day. This finding suggests that eliminat-
ing within-day variability would substantially 
reduce within-child relative to between-child 
variability overall. However, we found that 
65% of the total variance in 24-hr urine sam-
ples collected 3 days apart was due to within-
child between-day variability, even though 
the 24-hr samples reflect complete sampling 
with no within-day variability (i.e., the entire 
sample was collected). These apparently con-
tradictory findings suggest to us that the vari-
ance component analyses may overestimate 
the within-person within-day variance com-
ponent. Specifically, we suspect the  models 
may overestimate the degree of within-day 
variability that is biologically plausible, given 
that the total number of possible within-day 
observations is capped by the number of times 
individuals urinate each day, which in this 
study ranged between 3 and 12 times.
Our study provides important information 
about the appropriateness of creatinine adjust-
ment to control for urinary dilution in chil-
dren 3–6 years of age. Overall, our findings 
suggest that creatinine adjustment of urinary 
Table 3. Variance apportionment of log-transformed creatinine-adjusted DAP metabolite concentrations in spot urine samples collected during 1 week and in 
24-hr voids collected 3 days apart (n = 25 children).
Type of sample na
Total DAPs Total DMs Total DEs
Variance
Percent total 
variance ICC Variance
Percent total 
variance ICC Variance
Percent total 
variance ICC
Non-FMV spot samples 137
Between child 0.075 25 0.27b 0.114 27 0.30b 0.041 12 0.14b
Within child, between day 0.105 34 0.149 35 0.108 31
Within child, within day 0.125 41 0.162 38 0.198 57
FMV samples 110
Between child 0.105 34 0.34 0.172 38 0.39 0.035 12 0.11
Within childc 0.207 66 0.276 62 0.246 88
Any spot samples (FMV or Non-FMV) 247
Between child 0.097 31 0.32b 0.157 36 0.37b 0.033 10 0.11b
Within child, between day 0.064 20 0.070 16 0.049 15
Within child, within day 0.152 49 0.213 48 0.238 74
24-hr voids 50
Between child 0.089 35 0.35 0.131 36 0.026 16 0.16
Within childc 0.168 65 0.237 64 0.132 84
aNo. of samples used in calculation. bRatio of between-child to total variability as calculated using a one-factor (child) as opposed to a two-factor nested mixed-effects model. 
 cBecause FMV spots and 24-hr voids allow only one measure per day, the distinction between within-day versus between-day variability is not applicable. 
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DAP concentrations in children ages 3–6 years 
maximizes between-child relative to within-
child variance (thus reducing exposure misclas-
sification), improves estimation of the average 
24-hr DAP concentration on the basis of spot 
urine samples, and may decrease the differ-
ence between FMV and easier-to-collect non-
FMV spot samples in terms of their ability 
to estimate total 24-hr excretion. Despite this 
empirical evidence suggesting that creatinine 
adjustment effectively normalized the metabo-
lite concentrations, this method may intro-
duce other sources of variability. Specifically, 
creatinine varies as a function of sex, age, meat 
consumption, body size, and muscle mass 
(Boeniger et al. 1993). Thus, large differences 
in size, muscle mass, and diet between devel-
oping children of the same age could result 
in very different normalized metabolite val-
ues among children with the same exposure. 
In future analyses, we will examine creati-
nine excretion patterns in these children and 
assess adjustment for specific gravity (not yet 
quantified in these samples) as an alternative 
approach to account for urinary dilution.
In summary, our findings raise concerns 
about the utility of urinary DAP metabo-
lites as a biomarker of chronic OP pesticide 
exposure in young children. Two recent pub-
lished analyses from our Center have detected 
no association between DAP measures in chil-
dren and adverse outcomes, although they did 
detect significant associations between mater-
nal prenatal DAP measurements and child 
neurodevelopmental outcomes (Bouchard 
et al. 2011; Marks et al. 2010), despite the 
fact the we have also observed high within 
versus between variability in maternal urine 
(Bradman et al. 2005). One interpretation 
of this finding is that OP exposures in child-
hood are less critical than exposures that occur 
in utero: The fetus is so exceptionally sensi-
tive to OPs that the strength of the prenatal 
exposure effects are evident despite limitations 
in the exposure measure. The current study 
suggests another plausible explanation: that 
misclassification of child OP exposure biased 
results toward the null hypothesis.
Our study has several limitations. 
Collecting 24-hr urine samples from young 
children proved challenging, and missed voids 
due to occasional toileting accidents or other 
circumstances were beyond the control of 
study staff. Though 86% of the voids reported 
to have occurred during 24-hr sampling peri-
ods were collected, missed voids meant that 
individual spot samples made up a greater pro-
portion of the 24-hr volume-weighted average 
than they should have. Thus, our estimates 
of the association between metabolites in 
spot and 24-hr samples (Table 2) represent 
an upper bound. We measured class-specific 
organophosphate pesticide DAP metabolites, 
and our findings should not be generalized 
to pesticide-specific OP metabolites, which 
may exhibit different variance patterns. Our 
study was also conducted in an agricultural 
community during the growing season, and it 
is possible that intermittent exposures related 
to nearby agricultural pesticide use may have 
caused higher variability in metabolite levels 
than would be observed in the general U.S. 
population. Furthermore, different exposure 
scenarios could result in different variability 
patterns. Before the phaseout of diazinon and 
chlorpyrifos in household pesticides (U.S. 
Environmental Protection Agency 2000, 
2001), for example, children from homes with 
frequent indoor use of such pesticides may 
have shown more stable exposure levels. In a 
follow-up analysis, we intend to use additional 
data available to us to assess which potential 
exposure sources (e.g., diet, nearby agricultural 
pesticide use) best account for the metabolite 
variability patterns we present here.
Conclusions
We found that though DAP metabolites in 
single or multiple spot samples are strongly 
correlated with levels in same-day 24-hr sam-
ples, children’s urinary DAP concentrations 
vary greatly from day to day, and use of spot 
samples to characterize a child’s cumulative 
weekly exposure results in a moderate degree 
of misclassification. Exposure misclassification 
resulting from urinary metabolite variability 
has the potential to bias measures of associa-
tion between early childhood OP exposures 
and developmental outcomes in epidemio-
logic research toward the null hypothesis; 
such misclassification may account for the 
weak or null findings often reported to date 
between pediatric urinary DAP concentra-
tions and child development (Bouchard et al. 
2011; Marks et al. 2010). Additional research 
on variability in measures of nonpersistent 
compounds in children is needed to assure 
that exposure biomarkers are valid and that 
epidemiological studies have adequate power 
to detect health outcomes that may result 
from these exposures.
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